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A third etiologic f~lctor that ma! contrihutc to the ~>atliogcnesis of' neonatal h>pocalcemia in\.ol\.cs neonatal ( ' I ' ~>roJuction.
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In the neonate has not hcen prc\iousl! in\cstigarccl.
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SHAUL
To avoid the risks of hypermagnesemia during the study we excluded infants born to mothers who received MgS04 prior to delivery for the treatment of preeclampsia or for tocolysis (19, 20) . We also excluded infants with possible impairment in renal function on the day of study since Mg is primarily excreted by the kidney. Impaired renal function was determined by any of the following criteria: blood urea nitrogen concentration greater than 15 mg/dl, serum creatinine concentration greater than 1.2 mg/dl, or urine output less than 1.0 ml/kg body weight/h. Infants with serum Mg concentration of more than 2.5 mg/dl on day 1 or 2 of life were also excluded. By study design it was decided that hypocalcemia (serum total Ca concentration <7 mg/dl) would not be treated with Ca salts unless the infant was symptomatic, or the serum total Ca concentration was <6 mg/dl. None of the enrolled infants fulfilled those criteria and none received calcium supplementation prior to or during the study period.
The study was approved by the University of Cincinnati Human Research Committee and written informed parental consent was obtained at the time of enrollment.
The first 20 infants studied all received a MgS04 infusion. It was then decided that examination of Mg-induced changes in Ca metabolism by comparison to baseline measurements was insufficient, and a control group receiving a placebo infusion was formed. The subsequent patients enrolled were randomized to either MgS04 or placebo infusion in a double-blinded manner. The final study and control groups consisted of 29 and I0 infants, respectively. Since there were no differences between the earlier and later MgS04-infused infant groups, these are presented as a single MgS04 infusion group.
The study was performed at 72 f 12 h of age. Infants who were on oral feedings were given nothing by mouth for 4 h prior to the infusion. Intravenous fluids were administered from 2 h preinfusion to 2 h postinfusion with the rate and composition determined by the physicians caring for the infant. The fluid rate was based on the patient's weight and postnatal age and it ranged from 80 to 110 ml/kg/day. Electrolytes added to the fluids included NaCl, 2 to 3 mEq/kg/day, and KCI, 1 to 2 mEq/kg/ day. Feedings were resumed 2 h postinfusion. Infants who were exclusively on intravenous fluids prior to the onset of the study remained on those fluids during the study period.
The infants who received the MgS04 infusion were given 6.0 mg elemental Mg/kg body weight as 5% MgS04 7 H 2 0 , 1.2 ml/ kg, added to the intravenous fluids for 1 h. This Mg dose is equal to an infant's approximate daily requirement of Mg and to the recommended dose of Mg for the acute treatment of hypomagnesemia (I 5). It is also a dose that we expected to keep the serum Mg concentration within normal range. The control infants received a placebo infusion of an equal volume of D j W ad&d to the intravenous fluids for 1 h. The 5% MgS04 7 H 2 0 and D,W vials were prepared, coded, and randomized by the Children's Hospital pharmacy. Serum Mg, Ca, PTH, and C T concentrations were measured preinfusion at time 0 (baseline) and at 1, 2, 6, 12, 24, and 48 h postinfusion. The volumes of blood sampled were in accordance with University of Cincinnati Human Research Committee guidelines, which stipulate that the total amount of blood drawn must be less than 5% of blood volume. When the size of an infant limited blood sampling, the priority specimens obtained were usually at 0, 1, and 6 h postinfusion.
During the infusion period the heart rate and respiratory rate were determined continuously and blood pressure was measured every 15 min. These precautions were taken to detect the development of respiratory depression or hypotension, which are theoretically possible complications of a Mg infusion (2 1-24). Side effects were not observed in any infant.
Serum Ca and Mg concentrations were measured by atomic absorption spectrophotometry (25). Serum PTH concentration was determined as outlined by Arnaud et al. (26) , with modifications that have been previously described (6). Antiserum was produced in guinea pigs in response to injection with partially purified bovine PTH. The antibody produced detects 1-84 PTH (27). Plasma obtained from chronic hemodialysis patients was employed as the standard. '251-labeled highly-purified bovine PTH was used in the radioimmunoassay. The normal adult range is 33-1 17 fil Eq/ml, with intraassay and interassay coefficicnts of variation of 8 and 15%, respectively. Serum CT concentration was measured by a modification of the radioimmunoassay procedure described by Heath and Sizemore (14, 28) . Normal adult values are less than 107 pg/ml, with intraassay and interassay coefficients of variation of 6 and 15%. respectively.
Statistical analysis was performed using repeated measures analysis, analysis of variance, and linear regression methods for continuous data. Discrete data were analyzed by the x 2 test.
When the number of patients in any of the cells was less than 5, the Fisher-exact test was employed. The BMDP statistical package was utilized for repeated measurement analyses (29), and the SAS package for analysis of variance and linear regression (30).
Results are expressed as mean + SEM. A p value of <0.05 is considered significant.
RESULTS
The clinical characteristics of the infants studied are depicted in Table 1 . Gestational age, as determined by history from the mother's last menstrual period, and birth weight were similar for the two groups. The number of infants who were small for gestational age (birth weight less than the 10th percentile for gestational age), large for gestational age (birth weight greater than the 90th percentile for gestational age), and appropriate for gestational age (birth weight between the 10th and 90th percentile for gestational age) (3 1) were also similar for the two groups. The rate of birth asphyxia, defined by a I-min Apgar score less than 7, and the number of infants born to mothers with insulindependent diabetes also did not differ between the groups. Serum Mg concentrations for both groups are shown in Table  2 . Baseline serum Mg was similar for the two groups. In the study group the serum Mg increased from 1.80 f 0.06 to 2.82 t-0.07 mg/dl ( p < 0.001) by the end of the MgS04 infusion, and it then slowly declined back to baseline by 48 h postinfusion. In the control group there was no change in serum Mg concentration throughout the study period.
Baseline serum PTH concentrations were similar for the control and MgSO, infusion groups (Table 3 ). The two groups were therefore pooled together to examine the relationships between baseline serum PTH concentrations and serum Mg and Ca concentrations. Baseline PTH correlated with baseline Mg (r = 0.72, p < 0.005) and with baseline Ca ( r = 0.68, p < 0.005). Table 3 reveals that there was no change in mean serum PTH concentration during the study period in either the control or MgS04 infusion groups. However, in the MgS04 infusion group the absolute change from baseline in serum PTH 
Examination of
SGA n (%)
(20) 5 (17)
AGA n (%)
(70) 21 (72)
LGA n (%)
1(10) 3 (10)
Birth asphyxia n (%)
(50) 1(52)
* SGA, small for gestational age; AGA, appropriate for gestational age;
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I lie \cr-~lrn Mg concentr:itlc~li t'ollo\\ing thc blgSOI inl'lrhion remained within or c~lo\e to tlic 11o1-ma1 iallgc li)r neonate\. \ \ . l i~c~l l is I .5 to 2.8 rng/dl ( 1 5-17). I'his per-niittcil tlie c\aluatron ol'tlic~ effects of Mg on PTH and C T secretion in ranges of serum Mg concentration that were close to probable "physiologic" concentrations as opposed to "pharmacologic" ones. In the present study the serum Mg concentration has been treated as a continuous variable. The infants were not placed into hypomagnesemia versus normomagnesemia groups because serum Mg concentration generally has been considered to be a "poor" index of tissue Mg status; Mg is mainly an intracellular ion (33). When serum Mg concentrations are reduced, tissue Mg stores indeed may have been depleted; but in the normal ranges of serum Mg concentrations it has been difficult to assess tissue Mg status. Apparently, reduced tissue Mg stores can be associated with normal serum Mg concentrations (34, 35) . The relationship between tissue Mg status and serum Mg concentration in the newborn human or animal remains unclear.
The present findings support the hypothesis that the PTH response to Mg administration is inversely related to initial serum Mg status. The linear regression analyses of the baselinc Mg, Ca, and PTH data demonstrate the close relationships that exist among serum Mg, serum Ca, and serum PTH concentrations in the neonatal period. The role of Mg in neonatal parathyroid gland function is not evident, however, until one examines the influence of baseline Mg status on the parathyroid response to Mg infusion. The change in serum PTH concentration following MgSO, administration was inversely related to the baseline serum Mg concentration. Infants with a comparatively low initial serum Mg concentration responded to Mg infusion with an increase in serum PTH concentration, while infants with a comparatively high initial serum Mg concentration had a decrease in serum PTH concentration postinfusion.
Two previous studies have indirectly examined the neonatal parathyroid response to Mg administration. Donovan et a/. (19) studied the effect of maternally administered MgSO, on neonatal serum PTH concentrations during the first 3 days of life. The mean serum Mg concentration was 4.8 mg/dl in cord blood samples and it remained above 3.0 mg/dl for the following 3 days. Throughout the study period the serum PTH concentration was decreased compared to control infants (18). In a similar study Cruikshank el a/. (20) also found that infants born to MgS0,-treated mothers had decreased serum PTH concentrations in cord blood compared to controls. In contrast to the present study, the neonates in both these reports were overtly hypermagnesemic and their baseline Mg status prior to maternal MgSO, infusion was unknown.
Rude et 01. (32) compared the PTH response to Mg administration in Mg-deficient and normal adult subjects. The Mgdeficient adult patients responded with an increase in serum change in the serum PTH concentration. Thus, the response we found in infants with low serum Mg concentrations resembles that of Mg-deficient adults, and the response in neonates with higher serum Mg concentrations resembles that of normal adults.
The serum Ca response to MgS0, infusion was similar to the PTH response in that it also was inversely related to the baseline serum Mg concentration. Infants with a comparatively low initial serum Mg concentration responded to the infusion with an increase in serum Ca concentration, while infants with a comparatively high initial serum Mg concentration had a decrease in serum Ca concentration postinfusion. The observed changes in serum Ca concentration could be in part due to the effects of MgS0, administration on PTH secretion, since changes in serum PTH affect directly and positively the serum Ca concentration. There were infants, however, who responded to the MgS0, infusion with increases in serum Ca concentration who did not have measurable increases in serum PTH concentration. For example, at 2 h postinfusion sevcn of 10 infants who had increased serum Ca compared to baseline did not have an associated increase in serum PTH concentration. A possible explanation is that Mg administration in these infants resulted in increased exchange of Mg for Ca at the bone surface, shifting Ca from bone to the extracellular space, with a subsequent increase in serum Ca concentration (36). Such a mechanism may account for the observed increase in serum Ca concentration despite decreased serum PTH concentration in the previous cited study of neonatal hypermagnesemia by Donovan ct 01. ( 1 9).
There was no change in serum C T concentration in response to MgS0, administration. In a previous study of the effects of maternal MgSO, treatment on perinatal Ca metabolism, cord blood C T concentrations in Mg-treated neonates did not differ from controls (19). In the present study, the trend of declining serum C T concentrations over the study period is consistent with the results obtained in investigations of the C T status of infants during the first 2 wk of life (14, 37) .
In summary, Mg infusion in the neonatal period resulted in changes in serum PTH and Ca concentrations that were inversely related to the baseline serum Mg concentration, consistent with the hypothesis tested. Elevation of serum Ca concentration following Mg administration may be due to increased PTH secretion and/or increased exchange of Mg for Ca at bone surfaces. CT secretion was not affected by Mg administration. Mg status appears to exert important effects on neonatal Ca homeostasis.
